Tag: covid

1. An estimated 1 562 000 children lost at least one primary or secondary caregiver due to the COVID-19 pandemic. 2. Countries that had caregiver deaths over 1 per 1000 children included Peru, South Africa, Mexico, Brazil, Colombia, Iran, USA, Argentina, and Russia. Evidence Rating Level: 3 (Average) Study Rundown: While vaccine...
1. This meta-analysis found increased prevalence rates of clinically elevated anxiety and depression symptoms among youth during the COVID-19 pandemic. 2. Higher prevalence rates in data collected later in the pandemic, older adolescents, and females, as determined through moderator analysis, suggested that individual differences need to be considered when determining...
1. The risk of SARS-CoV-2 infection was nearly 4-fold higher among health care workers working on COVID-19 inpatient wards compared to workers not in patient care, suggesting increased risk from nosocomial infection in this population. 2. Combined phylogenetic and epidemiological analyses found no patient-to-health care worker transmission but several health...
Levels of antibodies against the trimeric spike protein and receptor-binding domain were 36- and 77-fold higher in the BNT162b2 group compared to control. There were no vaccine-related serious adverse events. Evidence Rating Level: 1 (Excellent)  Study Rundown: Current research on COVID-19 vaccination has revolved around a homologous dosing schedule (administering the...
1. Older age, male sex, and pre-existing comorbidities were independent risk factors for developing complications following COVID-19 infection. 2. The most common complications included renal, complex respiratory, systemic, and cardiovascular. Evidence Rating Level: 2 (Good)  Study Rundown: Patients hospitalized with COVID-19 are likely to develop in-hospital complications which may worsen their prognosis....
1. Incidence of PCR-confirmed symptomatic COVID-19 cases was lower in the vaccine group compared with the placebo group (p<0.0001). 2. The majority of adverse events were mild and there was no vaccine-related mortality.  Evidence Rating Level: 1 (Excellent) Study Rundown: Inactivated vaccines offer a variety of benefits against transmission of severe acute...
1. Levels of antibodies against the trimeric spike protein and receptor-binding domain were 36- and 77-fold higher in the BNT162b2 group compared to control. 2. There were no vaccine-related serious adverse events. Evidence Rating Level: 1 (Excellent)  Study Rundown: Current research on COVID-19 vaccination has revolved around a homologous dosing schedule (administering...
1. After receiving the BNT162b2 SARS-CoV-2 vaccine, fewer cancer patients demonstrated seropositivity for COVID antibodies compared to age-matched healthy controls, but those that were seropositive had comparable titers to healthy controls. 2. The COVID vaccine was found to have an acceptable safety profile amongst cancer patients currently on treatment, with...